OSD on CAR-T: Preclinical Assessment of Potential for Secondary Malignancies - Clinical

When:  Jun 16, 2025 from 12:00 to 13:00 (ET)

๐Ÿ”ฌ AAPS Open Scientific Discussion (OSD) ๐Ÿ”ฌ

CAR-T:  Preclinical Assessment of Potential for Secondary Malignancies

Co-sponsored by the GCTP and BPM Communities

๐Ÿ“… Date: Monday, June 16, 2025

๐Ÿ•› Time: 12:00 PM โ€“ 1:00 PM Eastern Time

๐Ÿ“ Location: Virtual Seminar @ https://global.gotomeeting.com/join/271724949

๐Ÿงช OSD Overview

Join us for an engaging 1-hour discussion featuring:

Dr. Gabriela Hernandez Hoyos (BMS) and Dr. Ilayaraja Muthuramu (J&J)
Experts in genomic risk analysis and safety assessments of CAR T platforms

They will explore:

โ—        Genomic risks in lentiviral vs. gene-edited CAR T products

โ—        Key molecular and functional assays used in risk assessment

โ—        Preclinical safety challenges in autologous vs. allogeneic approaches

โ—        Insights from published case studies and FDA-approved testing strategies

๐Ÿง  Who Should Attend?

Scientists, researchers, and professionals working in:
- Gene and cell therapy
- Regulatory science
- Oncology R&D
- Translational medicine

๐Ÿ”— Why Attend?

- Hear from leaders in the field
- Participate in an open discussion on safety assessment strategies
- Gain insights into regulatory and translational approaches for CAR T therapies

๐ŸŽฏ Add to Your Calendar Now & Share with Colleagues!

Look for this event on AAPS Communities and LinkedIn soon.

Download to Your Calendar Outlook Google

Contact

Carmen Fernandez-Metzler

[email protected]